TORONTO, ON--(Marketwired - November 18, 2013) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce its wholly-owned subsidiary, AllStar Health Brands Inc., has received their first purchase order of TapouT pain relief and muscle recovery products from California-based Delivery Agent, Inc. (http://www.deliveryagent.com/).

Delivery Agent, Inc. is a leader in shopping-enabled programming and content monetization for more than 350 entertainment properties and brands such as the UFC, Boston Celtics, New York Knicks, CBS, NBC Universal, Twentieth Century Fox, A+E Networks, HBO, and now the TapouT brand. Delivery Agent, Inc. was also recently named the #1 Privately Held Media Company by Inc. Magazine, and #3 on the Deloitte & Touche Silicon Valley Technology Fast 50.

In addition to Delivery Agent, Inc.'s recent order, Axxess Pharma's wholly owned subsidiary AllStar Health Brands' TapouT products will now be available to customers around the world through a number of websites including http://www.tapout.com/, http://www.supplementsource.ca/ and http://www.vitamart.ca/. Millions of customers from around the world visit TapouT.com each month. TapouT also has over 130,000 followers on Twitter.

Daniel Bagi, M.D. President of Axxess Pharma Inc., stated, "This is an exciting time for Axxess Pharma as we are delivering on our goal of initiating sales this month. Thanks to TapouT's large following through Tapout.com and Twitter, we anticipate a rapid increase in sales over the coming months. Tapout.com is the first website offering our line of topical pain relief and muscle recovery products to go along with its own core offerings of TapouT apparel. Further, our TapouT products are available through leading retailers which service Canadian and USA customers."

About Axxess Pharma Inc.:

Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain -- to optimal health management through improved nutritional supplements.

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.